For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of GUFIC BIOSCIENCE. For more details, see the GUFIC BIOSCIENCE quarterly results and GUFIC BIOSCIENCE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.3 |
No. of shares | m | 96.94 |
1 Week | % | -1.8 |
1 Month | % | 4.0 |
1 Year | % | 53.2 |
52 week H/L | Rs | 364.0/192.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
GUFIC BIOSCIENCE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 164 | 94 | 137 | 270 | 290 | |
Low | Rs | 65 | 38 | 45 | 108 | 177 | |
Sales per share (Unadj.) | Rs | 45.1 | 39.1 | 50.3 | 80.4 | 71.2 | |
Earnings per share (Unadj.) | Rs | 2.8 | 2.3 | 4.6 | 9.9 | 8.2 | |
Diluted earnings per share | Rs | 2.3 | 2.3 | 4.6 | 9.9 | 8.2 | |
Cash flow per share (Unadj.) | Rs | 3.4 | 3.8 | 6.2 | 11.8 | 10.5 | |
Dividends per share (Unadj.) | Rs | 0.05 | 0.05 | 0.10 | 0.10 | 0.10 | |
Adj. dividends per share | Rs | 0.04 | 0.05 | 0.10 | 0.10 | 0.10 | |
Avg Dividend yield | % | 0 | 0.1 | 0.1 | 0.1 | 0 | |
Book value per share (Unadj.) | Rs | 9.7 | 13.3 | 17.9 | 27.8 | 35.9 | |
Adj. book value per share | Rs | 7.8 | 13.3 | 17.9 | 27.8 | 35.9 | |
Shares outstanding (eoy) | m | 77.83 | 96.94 | 96.94 | 96.94 | 96.94 | |
Price / Sales ratio | x | 2.5 | 1.7 | 1.8 | 2.3 | 3.3 | |
Avg P/E ratio | x | 40.7 | 28.1 | 20.0 | 19.1 | 28.4 | |
P/CF ratio (eoy) | x | 33.6 | 17.4 | 14.6 | 16.0 | 22.2 | |
Price / Book Value ratio | x | 11.9 | 4.9 | 5.1 | 6.8 | 6.5 | |
Dividend payout | % | 1.8 | 2.1 | 2.2 | 1.0 | 1.2 | |
Avg Mkt Cap | Rs m | 8,941 | 6,372 | 8,832 | 18,308 | 22,620 | |
Total wages/salary | Rs m | 468 | 586 | 662 | 856 | 867 |
GUFIC BIOSCIENCE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 3,508 | 3,788 | 4,877 | 7,792 | 6,906 | |
Other income | Rs m | 42 | 58 | 37 | 31 | 26 | |
Total revenues | Rs m | 3,549 | 3,846 | 4,914 | 7,823 | 6,932 | |
Gross profit | Rs m | 460 | 521 | 839 | 1,480 | 1,347 | |
Depreciation | Rs m | 46 | 139 | 163 | 189 | 223 | |
Interest | Rs m | 102 | 139 | 136 | 54 | 82 | |
Profit before tax | Rs m | 353 | 301 | 577 | 1,268 | 1,067 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 134 | 74 | 135 | 310 | 270 | |
Profit after tax | Rs m | 219 | 227 | 442 | 958 | 797 | |
Gross profit margin | % | 13.1 | 13.8 | 17.2 | 19.0 | 19.5 | |
Effective tax rate | % | 37.9 | 24.7 | 23.4 | 24.4 | 25.3 | |
Net profit margin | % | 6.3 | 6.0 | 9.1 | 12.3 | 11.5 |
GUFIC BIOSCIENCE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 2,639 | 2,733 | 2,879 | 3,208 | 4,641 | |
Current liabilities | Rs m | 2,177 | 2,398 | 1,910 | 1,864 | 2,882 | |
Net working cap to sales | % | 13.2 | 8.9 | 19.9 | 17.2 | 25.5 | |
Current ratio | x | 1.2 | 1.1 | 1.5 | 1.7 | 1.6 | |
Inventory Days | Days | 13 | 20 | 14 | 21 | 35 | |
Debtors Days | Days | 1,074 | 1,031 | 932 | 710 | 1,086 | |
Net fixed assets | Rs m | 463 | 1,336 | 1,315 | 2,006 | 3,961 | |
Share capital | Rs m | 78 | 97 | 97 | 97 | 97 | |
"Free" reserves | Rs m | 676 | 1,196 | 1,637 | 2,594 | 3,381 | |
Net worth | Rs m | 753 | 1,293 | 1,734 | 2,691 | 3,478 | |
Long term debt | Rs m | 113 | 195 | 354 | 480 | 1,907 | |
Total assets | Rs m | 3,102 | 4,069 | 4,194 | 5,214 | 8,602 | |
Interest coverage | x | 4.5 | 3.2 | 5.2 | 24.6 | 14.0 | |
Debt to equity ratio | x | 0.2 | 0.2 | 0.2 | 0.2 | 0.5 | |
Sales to assets ratio | x | 1.1 | 0.9 | 1.2 | 1.5 | 0.8 | |
Return on assets | % | 10.3 | 9.0 | 13.8 | 19.4 | 10.2 | |
Return on equity | % | 29.1 | 17.5 | 25.5 | 35.6 | 22.9 | |
Return on capital | % | 52.5 | 29.6 | 34.2 | 41.7 | 21.3 | |
Exports to sales | % | 8.7 | 11.0 | 11.5 | 9.4 | 12.5 | |
Imports to sales | % | 13.6 | 20.7 | 22.5 | 29.5 | 39.3 | |
Exports (fob) | Rs m | 306 | 418 | 561 | 732 | 860 | |
Imports (cif) | Rs m | 478 | 786 | 1,097 | 2,300 | 2,716 | |
Fx inflow | Rs m | 306 | 418 | 561 | 732 | 860 | |
Fx outflow | Rs m | 478 | 786 | 1,097 | 2,300 | 2,716 | |
Net fx | Rs m | -172 | -368 | -536 | -1,569 | -1,855 |
GUFIC BIOSCIENCE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 52 | 471 | 873 | 1,062 | -266 | |
From Investments | Rs m | -130 | -425 | -67 | -946 | -1,907 | |
From Financial Activity | Rs m | 77 | -42 | -786 | -62 | 2,343 | |
Net Cashflow | Rs m | -1 | 4 | 19 | 54 | 170 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Jayesh P Choksi | COMP SEC: Ami Shah | YEAR OF INC: 1984 | BSE CODE: 509079 | FV (Rs): 1 | DIV YIELD (%): 0.0 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare GUFIC BIOSCIENCE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.